We recently updated our Privacy Notice and Terms of Use.
Med-IQ

Course Listings: Oncology

All Results (10)
Format: Live Events (0) Online Activities (10)

GFR and eGFR: Filtering Out the Confusion

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: Nephrologist Dr. Michael Wiederkehr delves into chronic kidney disease (CKD) and the difference between true glomerular filtration rate (GFR) and estimated glomerular filtration rate (eGFR). The different methods of calculating eGFR will be explored as well as the pitfalls and limitations of the current formulas and calculations. The importance of the CKD…More


Decision-IQ: Assessing Risk and Preventing Tumor Lysis Syndrome

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This brief case-based, digital CME activity incorporates current evidence-based prophylaxis algorithms to assess the risk of tumor lysis syndrome (TLS) in a patient with chronic lymphocytic leukemia (CLL) undergoing anticancer therapy. Links to relevant literature and expert insights are provided to help clinicians prevent and manage TLS.


Decision-IQ: Prostate Cancer Screening in the Geriatric Population

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This interactive case-based activity discusses the risks and benefits of prostate cancer screening in the geriatric population. Links to useful resources are provided to help participants make treatment decisions for the patient, and expert faculty offer their perspectives on the latest evidence for these management decisions.


Raising the Bar in NHL Through the Provision of Shared Decision Making

View Course

Format: E-Publication

Maximum Credits: 0.5

Course Description: This 30-minute, interactive digital publication interweaves clinical patient cases as well as patient, caregiver, and clinician insights from national surveys to examine the role of shared decision making in non-Hodgkin lymphoma. Evidence-based guideline recommendations for managing patients with follicular lymphoma and diffuse large B-cell lymphoma, as well as…More


Decision-IQ: Updates in the Diagnosis and Treatment of an Ocular Surface Mass

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this brief case-based activity, meet Bob, a 62-year-old man who initially presented with redness in his left eye and was referred to the Duke Eye Center. As you move through this activity, read through links to useful resources to help you make clinical management decisions for Bob. You will also receive insights from expert faculty Gargi Vora, MD, on the…More


Decision-IQ: Genetic Risk Assessment and Testing for Hereditary Ovarian Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this brief case-based activity, meet Karen, a fictional 30-year-old woman whose mother recently died of ovarian cancer. Karen is now asking whether she should undergo genetic testing or ovarian cancer screening. As you move through this activity, read through links to useful resources to help you make clinical management decisions for Karen. You will also…More


Keeping Up With CDK 4/6 Therapy in HR-Positive, HER2-Negative Advanced Breast Cancer

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: This online CME publication explores the changing treatment landscape in hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. In particular, it addresses questions related to the appropriate use of cyclin-dependent kinase 4/6 inhibitors in practice and details their similarities and…More


The Rapidly Evolving Role of Biosimilars: Educating Specialists and Facilitating Shared Decision Making With Patients

View Course

Format: E-Publication

Maximum Credits: 0.75

Course Description: This accredited CME publication describes biosimilars and how they compare with their originator products, reviews FDA guidance on the biosimilar approval process, and discusses key issues for prescribers. In addition, brief clinical case vignettes present examples of how biosimilars may appear in practice.


Improving Non-Hodgkin Lymphoma Care: What Do Patients Need to Know?

View Resource

Format: Simulation

Course Description: This simulation-based, interactive platform delivers education to patients with non-Hodgkin lymphoma (NHL) and their caregivers in short video segments that explore current and emerging treatment options, as well as critical elements of NHL diagnosis and staging. The side effects associated with different treatment modalities and modes of chemotherapy…More

Note: This material is not accredited for CME and, therefore, does not offer any CME/CE credit.


The Use of Molecular Biomarkers in Colon Cancer

View Course

Format: Med-IQ Express

Maximum Credits: 0.25

Course Description: In this Med-IQ Express activity, faculty describe the rationale for using molecular markers in the diagnosis and prognosis of colon cancer.